Mota, Nina Roth https://orcid.org/0000-0003-3504-759X
Poelmans, Geert
Klein, Marieke https://orcid.org/0000-0001-8784-5679
Torrico, Bàrbara
Fernàndez-Castillo, Noèlia
Cormand, Bru
Reif, Andreas https://orcid.org/0000-0002-0992-634X
Franke, Barbara https://orcid.org/0000-0003-4375-6572
Arias Vásquez, Alejandro
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (667302)
EC | Horizon 2020 Framework Programme (667302)
EC | Horizon 2020 Framework Programme (667302)
EC | Horizon 2020 Framework Programme (643051)
EC | Horizon 2020 Framework Programme (667302)
EC | Horizon 2020 Framework Programme (728018)
EC | Horizon 2020 Framework Programme (643051)
EC | Horizon 2020 Framework Programme (667302)
EC | Horizon 2020 Framework Programme (728018)
EC | Horizon 2020 Framework Programme (643051)
Centro de Investigación Biomédica en Red de Enfermedades Raras
Ministerio de Economía y Competitividad (SAF2015-68341-R)
Generalitat de Catalunya (2017-SGR-738)
Deutsche Forschungsgemeinschaft (SFB CRC 1193 Z03)
Bundesministerium für Bildung und Forschung (BipoLife)
European College of Neuropsychopharmacology (ADHD across the Lifespan)
European College of Neuropsychopharmacology (ADHD across the Lifespan)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016-130-669)
Article History
Received: 8 June 2019
Revised: 25 November 2019
Accepted: 27 November 2019
First Online: 2 January 2020